Direct inoculation on Phoenix panels for identification and antimicrobial susceptibility from positive BACTEC cultures: First study from India

Donay, 2004, Evaluation of the automated Phoenix system for potential routine use in the clinical microbiology laboratory, J Clin Microbiol, 42, 1542, 10.1128/JCM.42.4.1542-1546.2004 Stefaniuk, 2003, Evaluation of the BD Phoenix automated identification and susceptibility testing system in clinical microbiology laboratory practice, Eur J Clin Microbiol Infect Dis, 22, 479, 10.1007/s10096-003-0962-y Funke, 2004, Use of the BD PHOENIX Automated Microbiology System for Direct Identification and Susceptibility Testing of Gram-Negative Rods from Positive Blood Cultures in a Three-Phase Trial, J Clin Microbiol, 42, 1466, 10.1128/JCM.42.4.1466-1470.2004 Food and Drug Administration. Class II Special Controls Guidance Document: Antimicrobial Susceptibility Test Systems; Guidance for Industry and FDA. U.S. Department of Health and Human Services. March 5, 2007. Available from: http://www.fda.gov/cdrh/oivd/guidance/631.html. [Last accessed on 2011 Mar 30]. 2010 Trenholme, 1989, Clinical impact of rapid identification and susceptibility testing of bacterial blood culture isolates, J Clin Microbiol, 27, 1342, 10.1128/JCM.27.6.1342-1345.1989 Ling Thomas, 2003, Evaluation of the VITEK 2 System for rapid direct identification and susceptibility testing of gram-negative bacilli from positive blood cultures, J Clin Microbiol, 41, 4705, 10.1128/JCM.41.10.4705-4707.2003 Chung, 2009, Evaluation of MicroScan and Phoenix System for rapid identification and susceptibility testing using direct inoculation from positive BACTEC blood culture bottles, Korean J Lab Med, 29, 25 Lupetti, 2010, Rapid identification and antimicrobial susceptibility testing of Gram-positive cocci in blood cultures by direct inoculation into the BD Phoenix system, Clin Microbiol Infect, 16, 986, 10.1111/j.1469-0691.2009.03006.x